Ryght AI's Clinical Research Platform Now on Microsoft Azure Marketplace
Ryght AI has announced the availability of its advanced clinical research platform on the Microsoft Azure Marketplace, announced in a press release. This integration allows healthcare organizations to leverage Azure's cloud infrastructure to enhance the efficiency of clinical trials.
The platform utilizes AI Site Twins, dynamic digital models of clinical research sites, to automate site selection and optimize trial workflows. By being available on Azure Marketplace, Ryght AI's platform offers streamlined deployment and management, enabling organizations to use their existing Azure cloud commitments for cost-effective access.
This move simplifies procurement processes and integrates seamlessly with existing Azure environments, providing a unified view of cloud service utilization and costs. The platform's SOC Type 2-compliant architecture ensures real-time communication between sponsors, CROs, and research sites, addressing critical pain points in clinical trial processes.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Suvoda Updates Clinical Trial Platform With AI and Unified Access
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
SAS Releases AI Navigator on Microsoft Marketplace
TRI Launches TRIAL.OS for Clinical Trial Management
AbbVie Partners With Valkai on AI Tools for Clinical Development
Daily AI Brief: the AI news that matters, in your inbox.